Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial Frederick L. Locke , Armin Ghobadi , Caron A. Jacobson +28 more 2018 The Lancet Oncology 2108 citations